"Pharmacogenomics characterization of the MDM2 inhibitor MI-773 reveals candidate tumours and predictive biomarkers" by Vincent Vuaroqueaux, Hans R. Hendriks, Hoor Al-Hasani, Anne-Lise Peille, Samayita Das and Heinz-Herbert Fiebig, published on October 28, 2021, in the nature partner journal Precision Oncology 

"ProLiFiler and Cancer Data Miner, combined platforms for preclinical investigation to scrutinize impact of inhibitors on the KRAS, PI3K and MDM2 signaling pathways" by V. Vuaroqueaux et al., e-poster presented at the virtual AACR Annual Meeting in April/May 2021